Presented Friday, June 19, 2020
The COVID-19 global pandemic, caused by the SARS-CoV-2 coronavirus, highlights an urgent need for diagnostic reagents, antiviral therapeutics, and vaccine development. In this webinar, we will discuss GeneCopoeia’s advanced solutions including testing kits, SARS-CoV-2 pesudotyped virus, and other tools needed for research into combating this deadly disease.Watch recorded webinar / Download slides
Genome Editing
Title: Strategies For Effective CRISPR-Mediated Gene ModificationPresented Monday, December 3, 2018
CRISPR genome editing-the ability to make specific changes at targeted genomic sites-has transformed research in biology and medicine, due to its precision, ease of use, and relatively low cost. CRISPR’s many applications include gene knock out, gene tagging, correction of genetic defects, and gene activation. In this webinar, we discuss how to use GeneCopoeia’s CRISPR technology for efficient genome editing in mammalian cell lines.Watch recorded webinar / Download slides
Title: Harnessing CRISPR for Activation of Gene ExpressionPresented Wednesday, November 14, 2018
CRISPR-Cas systems have been successfully re-purposed from bacterial adaptive immune mechanisms for the modification of genes. Most CRISPR-mediated gene modifications include permanently changing the genetic code for such applications as gene knockout, mutagenesis, and fusion tagging. However, CRISPR-Cas has also been adapted for stimulating gene transcription, without modifying coding sequences. In this webinar, we discuss how GeneCopoeia CRISPR products and services can help you get more from your transcriptional activation applications.Watch recorded webinar/ Download slides
Title: Genome Editing: How Do I Use CRISPR?Presented Wednesday, February 22, 2017
Genome Editing-the ability to make specific changes at targeted genomic sites-is fundamentally important to researchers in biology and medicine. CRISPR is a very widely-used method for modifying specific genome sites, and can be used for many applications, including gene knock out, transgene knock in, gene tagging, and correction of genetic defects. However, researchers are often unaware of some of the work required to identify their desired modification in their cell lines. In this webinar, we discuss what you need to do for CRISPR genome editing after you have obtained your reagents from GeneCopoeia, the so-called “Downstream work”.
Watch recorded webinar / Download slides
Title: GeneCopoeia CRISPR Genome Editing TechnologyPresented Wednesday, January 25, 2017
The ability to make specific changes at targeted genomic sites in complex organisms is fundamentally important to researchers in biology and medicine. Researchers have developed and refined chimeric DNA endonucleases, such as CRISPR-Cas9, to stimulate double strand breaks at defined genomic loci, allowing the ability to insert, delete, and replace genetic information at will. These tools can also be used without nucleases to induce or repress gene transcription. In this webinar, we discuss CRISPR and other genome editing technologies and the applications they make possible, and provide information on GeneCopoeia’s powerful suite of genome editing products and services.
Watch recorded webinar / Download slides
Title: Applications For CRISPR-Cas9 Stable Cell LinesPresented Wednesday, March 22, 2017
The CRISPR-Cas9 system has become greatly popular for genome editing in recent years, due to its ease-of-design, efficiency, specificity, and relatively low cost. In mammalian cell culture systems, most genome editing is achieved using transient transfection or lentiviral transduction, which works well for routine, low-throughput applications. However, for other applications, it would be beneficial to have a system in which one component, namely the CRISPR-Cas9 nuclease, was stably integrated into the genome. In this webinar, we introduce GeneCopoeia’s suite of Cas9 stable cell lines, and discuss the great utility that these cell lines provide for genome editing applications.
Watch recorded webinar / Download slides
Title: Safe Harbor Transgenesis in Human & Mouse Genome EditingPresented Wednesday, April 19, 2017
Insertion of transgenes in mammalian chromosomes is an important approach for biomedical research and targeted gene therapy. Traditional lentiviral-mediated transgenesis is effective and straightforward, but its random integration can often be unstable and harm cells. “Safe Harbor” sites in human and mouse chromosomes have been employed recently as an alternative to random, viral-mediated integration because they support consistent, stable expression, and are not known to hamper cell fitness or growth. In this webinar, we will discuss the merits of Safe harbor transgenesis approaches, and how GeneCopoeia’s CRISPR tools for Safe Harbor knock-in can greatly benefit your research.
Watch recorded webinar / Download slides
Title: GeneCopoeia CRISPR sgRNA Libraries For Functional GenomicsPresented Wednesday, April 29, 2015
Biomedical researchers are enjoying a Renaissance in functional genomics, which aims to use a wealth of DNA sequence information—most notably, the complete sequence of the human genome—to determine the natural roles of the genes encoded by the genome. As a result, biochemical networks and pathways will be better understood, with the hope of leading to improved disease treatments. Researchers are turning increasingly to CRISPR (clustered, regularly interspaced, short palindromic repeats) for functional genomics studies. Several groups recently adapted CRISPR for high-throughput knockout applications, by developing large-scale CRISPR sgRNA libraries. GeneCopoeia recently launched a number of smaller, pathway- and gene group-focused CRISPR sgRNA libraries, which offer several key advantages over the whole-genome libraries. In this 40 minute webinar, we discuss the merits and applications for CRISPR sgRNA libraries, how to use CRISPR sgRNA libraries, the advantages of using small, pathway- and gene group-focused libraries, and how GeneCopoeia can help you with your high-throughput CRISPR knockout studies.
Watch recorded webinar / Download slides
Viral systems
Title: Chooing Between Lentivirus and Adeno-associated Virus For DNA DeliveryPresented Wednesday, April 12, 2017
Delivery of exogenous DNA to cultured cells and animals is a fundamental strategy for modern molecular biology, functional genomics, and gene therapy. While plasmid transfection is widely used for routine DNA delivery into cultured cells, the use of viral vectors is often advantageous, especially for cells that are refractory to transfection. Further, viral vectors remain the only practical option for DNA delivery to tissues in vivo. In this webinar, we will compare lentiviral systems with adeno-associated virus (AAV) systems, how to decide which system is appropriate for a specific scenario, and how GeneCopoeia’s powerful suite of lentiviral and AAV products and services can help you with your DNA delivery applications.
Watch recorded webinar / Download slides
Title: How To Use Lentivirus in Mammalian Cell LinesPresented Wednesday, June 27, 2018
Lentiviruses are useful gene delivery vehicles for many applications, including gene overexpression and gene knockout. Most lentiviral vectors are derived from human immunodeficiency virus (HIV), and have been modified to make them effective and safe. In this webinar, we describe how to use lentiviruses in cultured mammalian cells, and how GeneCopoeia can help you at every step of the way in your lentiviral packaging and transduction workflow.Watch recorded webinar / Download slides
Promoter-reporter clones
Title: Improved Promoter Reporter Technology For Understanding Gene RegulationPresented Wednesday, September 10, 2014
Identifying and characterizing DNA regulatory elements is critical for determining gene expression patterns. Typically, the strength of expression of reporters such as GFP or firefly luciferase is measured in response to environmental conditions, or to stimuli by growth factors or pharmacological agents. However, these assays are often laborious and time consuming, due to the requirement for fluorescence microscopy or cell lysis for reporter detection. In this 30 minute webinar, you will learn how GeneCopoeia provides improved promoter reporter detection technology through the use of Gaussia luciferase (GLuc) and secreted alkaline phosphatase (SEAP) in a dual reporter assay system. Both reporters are secreted by cells, and can be assayed in live cells quickly and conveniently.
Watch recorded webinar / Download slides
Gene Expression
Title: Unleash the Power of Luciferase to Analyze miRNA Activitiy in CancerPresented Monday, November 12, 2018
Micro RNAs (miRNAs) are critical modulators of gene expression in eukaryotes, and their dysregulation can lead to diseases such as cancers. Luciferases are luminescent reporters that, when fused to miRNA target sequences, offer the most powerful means to study miRNA function, due to their high signal intensity and low background. In this webinar, we will demonstrate how GeneCopoeia luciferase reporters and assay reagents have been used to unlock the secrets of miRNA activity in cancer.Watch recorded webinar / Download slides
Title: Functional Tags For ORF Clones in Your ResearchPresented Wednesday, February 19, 2014
Overexpression of proteins is commonly performed in functional genomics, proteomics and system biology studies. Fusing oligopeptide or protein tags to proteins is a popular strategy for the detection and purification of proteins when a suitable antibody recognizing the native protein is unavailable. GeneCopoeia is the original manufacturer of human and mouse expression-ready, full-length ORF cDNA clones. These clones are available with more than 50 classical, popular tags, as well as powerful multifunctional tags. In addition, GeneCopoeia is the only company with a comprehensive set of native expression clones. In this 45 minute webinar, we will tell you about the utility of the more powerful, next generation tags, and how GeneCopoeia’s extensive collection of tagged and native expression ready clones can greatly accelerate your research.